Fatal eosinophilic myocarditis develops in the absence of IFN-γand IL-17A

Journal of Immunology

Volumn 191, Issue 8, 2013, Pages 4038-4047

  Barin, Jobert G ^a,b   Baldeviano, G Christian ^b,c   Talor, Monica V ^a   Wu, Lei ^b   Ong, Su Fey ^b   De Fairweather, Lisa ^b   Bedja, Djahida ^a   Stickel, Natalie R ^d   Fontes, Jillian A ^b   Cardamone, Ashley B ^a   Zheng, Dongfeng ^a   Gabrielson, Kathleen L ^a   Rose, Noel R ^a,b   Čiháková, Daniela ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c California   (Peru)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; GAMMA INTERFERON; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CONGESTIVE CARDIOMYOPATHY; DISEASE SEVERITY; EOSINOPHIL; EXPERIMENTAL AUTOIMMUNE MYOCARDITIS; HEART MUSCLE CONTRACTILITY; HEART MUSCLE FIBROSIS; LYMPHOCYTIC INFILTRATION; MORTALITY; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; AUTOIMMUNE DISEASES; BIOLOGICAL MARKERS; CARDIAC MYOSINS; CARDIOMYOPATHIES; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINE CCL11; EOSINOPHILS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MALE; MICE; MICE, INBRED BALB C; MICE, KNOCKOUT; MYOCARDITIS; MYOCARDIUM; MYOSITIS;

EID: 84885444778     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301282     Document Type: Article

References (74)

1. Ciháková, D., and N. R. Rose. 2008. Pathogenesis of myocarditis and dilated cardiomyopathy. Adv. Immunol. 99: 95-114.
2. Andréoletti, L., N. Lévêque, C. Boulagnon, C. Brasselet, and P. Fornes. 2009. Viral causes of human myocarditis. Arch. Cardiovasc. Dis. 102: 559-568.
3. Afanasyeva, M., and N. R. Rose. 2004. Viral infection and heart disease: autoimmune mechanisms. In Infection and Autoimmunity. Y. Shoenfeld, and N. R. Rose, eds. Elsevier, Amsterdam, p. 299-Autoimmune mechanisms. In Infection and Autoimmunity. Y. Shoenfeld, and N. R. Rose, eds. Elsevier, Amsterdam, p. 299.
4. Rose, N. R. 2005. The Significance of Autoimmunity in Myocarditis. In Chronic Viral and Inflammatory Cardiomyopathy. H.-P. Schultheiss, J.-F. Kapp, and G. Grötzbach, eds. Springer Verlag, Düsseldorf, Germany, p. 141-154.
5. Eckart, R. E., S. L. Scoville, C. L. Campbell, E. A. Shry, K. C. Stajduhar, R. N. Potter, L. A. Pearse, and R. Virmani. 2004. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann. Intern. Med. 141: 829-834.
6. Ginsberg, F., and J. E. Parrillo. 2005. Eosinophilic myocarditis. Heart Fail. Clin. 1: 419-429.
7. Cooper, L. T., Jr. 2009. Myocarditis. N. Engl. J. Med. 360: 1526-1538.
8. Magnani, J. W., and G. W. Dec. 2006. Myocarditis: current trends in diagnosis and treatment. Circulation 113: 876-890.
9. Ciháková, D., R. B. Sharma, D. Fairweather, M. Afanasyeva, and N. R. Rose. 2004. Animal models for autoimmune myocarditis and autoimmune thyroiditis. Methods Mol. Med. 102: 175-193.
10. Neu, N., N. R. Rose, K.W. Beisel, A. Herskowitz, G. Gurri-Glass, and S.W. Craig. 1987. Cardiac myosin induces myocarditis in genetically predisposed mice. J. Immunol. 139: 3630-3636.
11. Smith, S. C., and P. M. Allen. 1991. Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 147: 2141-2147.
12. Weaver, C. T., R. D. Hatton, P. R. Mangan, and L. E. Harrington. 2007. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25: 821-852.
13. Baldeviano, G. C., J. G. Barin, M. V. Talor, S. Srinivasan, D. Bedja, D. Zheng, K. Gabrielson, Y. Iwakura, N. R. Rose, and D. Ciháková. 2010. Interleukin-17A is dispensable for myocarditis but essential for the progression to dilated cardiomyopathy. Circ. Res. 106: 1646-1655.
14. Kolls, J. K., and A. Lindén. 2004. Interleukin-17 family members and inflammation. Immunity 21: 467-476.
15. Iwakura, Y., H. Ishigame, S. Saijo, and S. Nakae. 2011. Functional specialization of interleukin-17 family members. Immunity 34: 149-162.
16. Gaffen, S. L. 2009. Structure and signalling in the IL-17 receptor family. Nat. Rev. Immunol. 9: 556-567.
17. Harrington, L. E., R. D. Hatton, P. R. Mangan, H. Turner, T. L. Murphy, K. M. Murphy, and C. T. Weaver. 2005. Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
18. Park, H., Z. Li, X. O. Yang, S. H. Chang, R. Nurieva, Y. H. Wang, Y. Wang, L. Hood, Z. Zhu, Q. Tian, and C. Dong. 2005. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 6: 1133-1141.
19. Veldhoen, M., R. J. Hocking, C. J. Atkins, R. M. Locksley, and B. Stockinger. 2006. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
20. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
21. Bettelli, E., Y. Carrier, W. Gao, T. Korn, T. B. Strom, M. Oukka, H. L. Weiner, and V. K. Kuchroo. 2006. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
22. Luger, D., P. B. Silver, J. Tang, D. Cua, Z. Chen, Y. Iwakura, E. P. Bowman, N. M. Sgambellone, C. C. Chan, and R. R. Caspi. 2008. Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J. Exp. Med. 205: 799-810.
23. Stummvoll, G. H., R. J. DiPaolo, E. N. Huter, T. S. Davidson, D. Glass, J. M. Ward, and E. M. Shevach. 2008. Th1, Th2, and Th17 effector T cellinduced autoimmune gastritis differs in pathological pattern and in susceptibility to suppression by regulatory T cells. J. Immunol. 181: 1908-1916.
24. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
25. Damsker, J. M., A. M. Hansen, and R. R. Caspi. 2010. Th1 and Th17 cells: adversaries and collaborators. Ann. N. Y. Acad. Sci. 1183: 211-221.
26. Hu, X., and L. B. Ivashkiv. 2009. Cross-regulation of signaling pathways by interferon-gamma: implications for immune responses and autoimmune diseases. Immunity 31: 539-550.
27. Eriksson, U., M. O. Kurrer, W. Sebald, F. Brombacher, and M. Kopf. 2001. Dual role of the IL-12/IFN-gamma axis in the development of autoimmune myocarditis: induction by IL-12 and protection by IFN-gamma. J. Immunol. 167: 5464-5469.
28. Afanasyeva, M., D. Georgakopoulos, D. F. Belardi, D. Bedja, D. Fairweather, Y. Wang, Z. Kaya, K. L. Gabrielson, E. R. Rodriguez, P. Caturegli, et al. 2005. Impaired up-regulation of CD25 on CD4+ T cells in IFN-gamma knockout mice is associated with progression of myocarditis to heart failure. Proc. Natl. Acad. Sci. USA 102: 180-185.
29. Afanasyeva, M., Y.Wang, Z. Kaya, E. A. Stafford, K. M. Dohmen, A. A. Sadighi Akha, and N. R. Rose. 2001. Interleukin-12 receptor/STAT4 signaling is required for the development of autoimmune myocarditis in mice by an interferongamma-independent pathway. Circulation 104: 3145-3151.
30. Barin, J. G., M. V. Talor, G. C. Baldeviano, M. Kimura, N. R. Rose, and D. Ciháková. 2010. Mechanisms of IFNg regulation of autoimmune myocarditis. Exp. Mol. Pathol. 89: 83-91.
31. Berghmans, N., A. Nuyts, C. Uyttenhove, J. Van Snick, G. Opdenakker, and H. Heremans. 2011. Interferon-g orchestrates the number and function of Th17 cells in experimental autoimmune encephalomyelitis. J. Interferon Cytokine Res. 31: 575-587.
32. Qian, X., H. Ning, J. Zhang, D. F. Hoft, D. J. Stumpo, P. J. Blackshear, and J. Liu. 2011. Posttranscriptional regulation of IL-23 expression by IFN-gamma through tristetraprolin. J. Immunol. 186: 6454-6464.
33. Nakae, S., Y. Iwakura, H. Suto, and S. J. Galli. 2007. Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J. Leukoc. Biol. 81: 1258-1268.
34. Koike, T. 2012. Interferon-g-independent suppression of Th17 cell differentiation by T-bet expression in mice with autoimmune arthritis. Arthritis Rheum. 64: 40-41.
35. Kelchtermans, H., E. Schurgers, L. Geboes, T. Mitera, J. Van Damme, J. Van Snick, C. Uyttenhove, and P. Matthys. 2009. Effector mechanisms of interleukin-17 in collagen-induced arthritis in the absence of interferon-gamma and counteraction by interferon-gamma. Arthritis Res. Ther. 11: R122.
36. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
37. Dalton, D. K., S. Pitts-Meek, S. Keshav, I. S. Figari, A. Bradley, and T. A. Stewart. 1993. Multiple defects of immune cell function in mice with disrupted interferongamma genes. Science 259: 1739-1742.
38. Care, C. U. G. t., U. L. Animals, and N. R. Council. 2011. Guide for the Care and Use of Laboratory Animals, 8th Ed. The National Academies Press, Washington, D.C.
39. Pummerer, C. L., K. Luze, G. Grässl, K. Bachmaier, F. Offner, S. K. Burrell, D. M. Lenz, T. J. Zamborelli, J. M. Penninger, and N. Neu. 1996. Identification of cardiac myosin peptides capable of inducing autoimmune myocarditis in BALB/c mice. J. Clin. Invest. 97: 2057-2062.
40. Fairweather, D., K. A. Stafford, and Y. K. Sung. 2012. Update on coxsackievirus B3 myocarditis. Curr. Opin. Rheumatol. 24: 401-407.
41. Fairweather, D., and N. R. Rose. 2007. Coxsackievirus-induced myocarditis in mice: a model of autoimmune disease for studying immunotoxicity. Methods 41: 118-122.
42. Livak, K. J., and T. D. Schmittgen. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
43. Edwards, C. A., and W. D. O'Brien, Jr. 1980. Modified assay for determination of hydroxyproline in a tissue hydrolyzate. Clin. Chim. Acta 104: 161-167.
44. Ciháková, D., J. G. Barin, M. Afanasyeva, M. Kimura, D. Fairweather, M. Berg, M. V. Talor, G. C. Baldeviano, S. Frisancho, K. Gabrielson, et al. 2008. Interleukin-13 protects against experimental autoimmune myocarditis by regulating macrophage differentiation. Am. J. Pathol. 172: 1195-1208.
45. Fairweather, D., S. Frisancho-Kiss, and N. R. Rose. 2005. Viruses as adjuvants for autoimmunity: evidence from Coxsackievirus-induced myocarditis. Rev. Med. Virol. 15: 17-27.
46. Fairweather, D., Z. Kaya, G. R. Shellam, C. M. Lawson, and N. R. Rose. 2001. From infection to autoimmunity. J. Autoimmun. 16: 175-186.
47. Fairweather, D., S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, R. A. Steele, S. J. Gatewood, and N. R. Rose. 2005. IL-12 protects against coxsackievirus B3-induced myocarditis by increasing IFN-gamma and macrophage and neutrophil populations in the heart. J. Immunol. 174: 261-269.
48. Fairweather, D., S. Frisancho-Kiss, S. A. Yusung, M. A. Barrett, S. E. Davis, S. J. Gatewood, D. B. Njoku, and N. R. Rose. 2004. Interferon-gamma protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming growth factor-beta 1, interleukin-1 beta, and interleukin-4 in the heart. Am. J. Pathol. 165: 1883-1894.
49. Shinkai, K., M. Mohrs, and R. M. Locksley. 2002. Helper T cells regulate type-2 innate immunity in vivo. Nature 420: 825-829.
50. Rothenberg, M. E., and S. P. Hogan. 2006. The eosinophil. Annu. Rev. Immunol. 24: 147-174.
51. Yu, C., A. B. Cantor, H. Yang, C. Browne, R. A. Wells, Y. Fujiwara, and S. H. Orkin. 2002. Targeted deletion of a high-Affinity GATA-binding site in the GATA-1 promoter leads to selective loss of the eosinophil lineage in vivo. J. Exp. Med. 195: 1387-1395.
52. O'Connor, W., Jr., M. Kamanaka, C. J. Booth, T. Town, S. Nakae, Y. Iwakura, J. K. Kolls, and R. A. Flavell. 2009. A protective function for interleukin 17A in T cell-mediated intestinal inflammation. Nat. Immunol. 10: 603-609.
53. Ogawa, A., A. Andoh, Y. Araki, T. Bamba, and Y. Fujiyama. 2004. Neutralization of interleukin-17 aggravates dextran sulfate sodium-induced colitis in mice. Clin. Immunol. 110: 55-62.
54. Kezic, J. M., T. T. Glant, J. T. Rosenbaum, and H. L. Rosenzweig. 2012. Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res. Ther. 14: R18.
55. Veldhoen, M., R. J. Hocking, R. A. Flavell, and B. Stockinger. 2006. Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol. 7: 1151-1156.
56. Eriksson, U., M. O. Kurrer, R. Bingisser, H. P. Eugster, P. Saremaslani, F. Follath, S. Marsch, and U. Widmer. 2001. Lethal autoimmune myocarditis in interferon-gamma receptor-deficient mice: enhanced disease severity by impaired inducible nitric oxide synthase induction. Circulation 103: 18-21.
57. Mosmann, T. R., and R. L. Coffman. 1989. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7: 145-173.
58. Khan, S., and S. R. Orenstein. 2008. Eosinophilic gastroenteritis. Gastroenterol. Clin. North Am. 37: 333-348, v (v.).
59. Nelson, A. M. 1996. Localized forms of scleroderma, including morphea, linear scleroderma, and eosinophilic fasciitis. Curr. Opin. Rheumatol. 8: 473-476.
60. Alfadda, A. A., M. A. Storr, and E. A. Shaffer. 2011. Eosinophilic colitis: an update on pathophysiology and treatment. Br. Med. Bull. 100: 59-72.
61. Afanasyeva, M., Y. Wang, Z. Kaya, S. Park, M. J. Zilliox, B. H. Schofield, S. L. Hill, and N. R. Rose. 2001. Experimental autoimmune myocarditis in A/J mice is an interleukin-4-dependent disease with a Th2 phenotype. Am. J. Pathol. 159: 193-203.
62. Abston, E. D., J. G. Barin, D. Ciháková, A. Bucek, M. J. Coronado, J. E. Brandt, D. Bedja, J. B. Kim, D. Georgakopoulos, K. L. Gabrielson, et al. 2012. IL-33 independently induces eosinophilic pericarditis and cardiac dilation: ST2 improves cardiac function. Circ Heart Fail 5: 366-375.
63. Cookston, M., M. Stober, and S. G. Kayes. 1990. Eosinophilic myocarditis in CBA/J mice infected with Toxocara canis. Am. J. Pathol. 136: 1137-1145.
64. Schaffer, S. W., E. R. Dimayuga, and S. G. Kayes. 1992. Development and characterization of a model of eosinophil-mediated cardiomyopathy in rats infected with Toxocara canis. Am. J. Physiol. 262: H1428-H1434.
65. Hirasawa, M., Y. Ito, M. A. Shibata, and Y. Otsuki. 2007. Mechanism of inflammation in murine eosinophilic myocarditis produced by adoptive transfer with ovalbumin challenge. Int. Arch. Allergy Immunol. 142: 28-39.
66. Endo, Y., C. Iwamura, M. Kuwahara, A. Suzuki, K. Sugaya, D. J. Tumes, K. Tokoyoda, H. Hosokawa, M. Yamashita, and T. Nakayama. 2011. Eomesodermin controls interleukin-5 production in memory T helper 2 cells through inhibition of activity of the transcription factor GATA3. Immunity 35: 733-745.
67. Rezaizadeh, H., M. Sanchez-Ross, E. Kaluski, M. Klapholz, B. Haider, and C. Gerula. 2010. Acute eosinophilic myocarditis: diagnosis and treatment. Acute Card. Care 12: 31-36.
68. Al Ali, A. M., L. P. Straatman, M. F. Allard, and A. P. Ignaszewski. 2006. Eosinophilic myocarditis: case series and review of literature. Can. J. Cardiol. 22: 1233-1237.
69. Cooper, L. T., and K. J. Zehr. 2005. Biventricular assist device placement and immunosuppression as therapy for necrotizing eosinophilic myocarditis. Nat. Clin. Pract. Cardiovasc. Med. 2: 544-548.
70. Roehrl, M. H., M. P. Alexander, S. B. Hammond, M. Ruzinova, J. Y. Wang, and C. J. O'Hara. 2011. Eosinophilic myocarditis in hypereosinophilic syndrome. Am. J. Hematol. 86: 607-608.
71. Gupta, S., D. W. Markham, M. H. Drazner, and P. P. Mammen. 2008. Fulminant myocarditis. Nat. Clin. Pract. Cardiovasc. Med. 5: 693-706.
72. Domingues, H. S., M. Mues, H. Lassmann, H. Wekerle, and G. Krishnamoorthy. 2010. Functional and pathogenic differences of Th1 and Th17 cells in experimental autoimmune encephalomyelitis. PLoS ONE 5: e15531.
73. Codarri, L., G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher. 2011. RORgt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation. Nat. Immunol. 12: 560-567.
74. Luna, L. 1968. Manual of Histologic Staining Methods of the Armed Forces Institute of Pathology. McGraw-Hill, New York.